Catalyst Wire Dossier Catalyst Wire Dossier

ABT-652

· AbbVie
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ABT-652, covering 2011-07-04 to 2013-09-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain [Phase 2]

See pricing